You’re cruising through a Q-bank block on chest pain when nitrates show up—again. The catch is that test writers rarely ask “what do nitrates do?” in isolation. They test mechanism → hemodynamics → clinical effect → contraindications → adverse effects, and they make sure every answer choice teaches a rule. Let’s break it down like you would on test day.
Tag: Cardiovascular > Cardiac Pharmacology
The Clinical Vignette (Q-bank style)
A 58-year-old man with hypertension and hyperlipidemia presents with 20 minutes of substernal chest pressure radiating to his left arm. ECG shows ST depressions in the lateral leads. He is given sublingual nitroglycerin, and his chest pain improves. Shortly after, his blood pressure drops and he develops a throbbing headache.
Which of the following best explains how nitroglycerin relieved his chest pain?
A. Decreases preload by venodilation, reducing myocardial oxygen demand
B. Increases coronary perfusion by selective dilation of epicardial coronary arteries
C. Decreases afterload by arteriolar dilation, reducing myocardial wall stress
D. Inhibits phosphodiesterase-5, increasing cGMP in vascular smooth muscle
E. Blocks L-type calcium channels in vascular smooth muscle, causing vasodilation
✅ Correct Answer: A. Decreases preload by venodilation, reducing myocardial oxygen demand
Why A Is Correct (Mechanism → Hemodynamics → Symptom Relief)
Step 1: Mechanism
Nitrates (e.g., nitroglycerin, isosorbide dinitrate/mononitrate) are prodrugs that generate nitric oxide (NO) in vascular smooth muscle.
NO activates guanylate cyclase → increases cGMP → activates myosin light-chain phosphatase → smooth muscle relaxation.
Step 2: The key hemodynamic effect
At typical clinical doses, nitrates predominantly cause venodilation.
- Venodilation → ↓ venous return → ↓ LV end-diastolic volume (preload)
- ↓ preload → ↓ LV radius → ↓ wall tension (Laplace)
- ↓ wall tension → ↓ myocardial oxygen demand → less angina
Step 3: The classic clinical tie-ins
- Relieves exertional (stable) angina by lowering demand
- Helpful in acute coronary syndromes (unstable angina/NSTEMI) for symptom control (not mortality benefit)
- Common side effects are exactly what the vignette gives you:
- Headache
- Hypotension
- Reflex tachycardia (can partially blunt benefit by increasing O₂ demand)
High-Yield Nitrate Pearls (USMLE favorites)
Hemodynamic summary
- ↓ Preload (venodilation > arteriolar dilation)
- Some ↓ afterload at higher doses
- Dilates large coronary arteries and relieves coronary vasospasm (Prinzmetal)
Adverse effects
- Headache, flushing
- Hypotension, orthostatic syncope
- Reflex tachycardia (often pair with a beta-blocker in chronic therapy to reduce this)
- Rare: methemoglobinemia (think excessive oxidant stress; cyanosis + “chocolate blood”)
Tolerance
- Tachyphylaxis with continuous exposure
→ prevent with a daily nitrate-free interval (often 10–12 hours overnight)
Absolute contraindication (testable)
- PDE-5 inhibitor use (sildenafil, tadalafil, vardenafil)
→ profound hypotension from excessive cGMP
Now Kill the Distractors (Why Each Wrong Choice Is Wrong)
B. “Increases coronary perfusion by selective dilation of epicardial coronary arteries”
Why it sounds tempting: Nitrates do dilate coronary vessels, and coronary perfusion matters.
Why it’s not the best answer: In typical exertional angina, the primary benefit is decreased myocardial oxygen demand via ↓ preload, not increased supply.
When coronary dilation is the point:
- Prinzmetal (variant) angina due to coronary vasospasm
- Nitrates + calcium channel blockers are first-line
USMLE takeaway:
For classic stable angina relief, think demand reduction (↓ preload) first.
C. “Decreases afterload by arteriolar dilation, reducing myocardial wall stress”
Partly true physiology: At higher doses, nitrates can dilate arterioles and reduce afterload.
Why it’s wrong here: Nitrates are more venoselective at standard anti-anginal dosing. If you’re asked for the best explanation, it’s preload reduction.
Compare with true afterload reducers:
- Hydralazine (arteriolar dilation → ↓ afterload)
- ACE inhibitors/ARBs (↓ afterload + remodeling benefits)
USMLE takeaway:
Nitrates = venodilation first. Hydralazine = arteriolar dilation.
D. “Inhibits phosphodiesterase-5, increasing cGMP in vascular smooth muscle”
This describes PDE-5 inhibitors, not nitrates.
- PDE-5 inhibitors prevent breakdown of cGMP → vasodilation
- Nitrates increase production of cGMP (via NO → guanylate cyclase)
Why test writers love this option: It’s the contraindication trap.
- Taking sildenafil + nitroglycerin → massive cGMP surge → life-threatening hypotension
USMLE takeaway:
Nitrates: “make cGMP.”
PDE-5 inhibitors: “save cGMP.”
E. “Blocks L-type calcium channels in vascular smooth muscle, causing vasodilation”
This is calcium channel blockers (CCBs), not nitrates.
- Dihydropyridines (amlodipine, nifedipine): vasodilation > heart effects
- Non-dihydropyridines (verapamil, diltiazem): more cardiac conduction effects
Where CCBs shine in angina:
- Prinzmetal angina (prevent vasospasm)
- Stable angina (↓ afterload; some ↓ heart rate with non-DHP)
USMLE takeaway:
If the stem emphasizes coronary vasospasm and episodic pain at rest, think CCBs + nitrates. If it emphasizes exertion-related demand, nitrates work mainly through preload reduction.
Rapid Comparison Table (Mechanisms You Must Not Mix Up)
| Drug class | Primary mechanism | Major hemodynamic effect | Classic use | Key warning |
|---|---|---|---|---|
| Nitrates | ↑ NO → ↑ cGMP | ↓ preload (venodilation) | Acute angina relief, ACS symptom control, Prinzmetal | No PDE-5 inhibitors, tolerance |
| PDE-5 inhibitors | ↓ cGMP breakdown | Vasodilation | ED, pulmonary HTN | No nitrates |
| CCBs | Block L-type Ca²⁺ channels | ↓ afterload (DHP); ↓ HR/contractility (non-DHP) | HTN, angina, Prinzmetal | Bradycardia/AV block (non-DHP), edema (DHP) |
| Hydralazine | Direct arteriolar relaxation | ↓ afterload | HTN (esp pregnancy), HF (w/ nitrates) | Reflex tachy, lupus-like syndrome |
How This Shows Up on Step: The “One-Line” Rules
- Nitrates relieve typical angina mainly by ↓ preload → ↓ wall stress → ↓ O₂ demand.
- Headache + hypotension after nitrates is expected; reflex tachycardia is a common follow-up concept.
- Do not combine nitrates with PDE-5 inhibitors (sildenafil/tadalafil/vardenafil).
- Tolerance requires a nitrate-free interval.
Quick Self-Check (2 Q-bank micro-variants)
-
Patient with chest pain at rest, transient ST elevations, responds to nitroglycerin: most likely diagnosis?
→ Prinzmetal angina (coronary vasospasm) -
Patient took tadalafil last night, now given nitroglycerin and becomes profoundly hypotensive: mechanism?
→ Excess cGMP-mediated vasodilation due to combined increased production (nitrate) + decreased breakdown (PDE-5 inhibitor)